Síndrome de Alport o nefropatía hereditaria hematúrica progresiva con sordera

Timpl, 1989, Structure and biological activity of basement membrane proteins, Eur. J. Biochem., 180, 487, 10.1111/j.1432-1033.1989.tb14673.x Tryggvason, 1996, Mutations in type IV collagen genes and Alport phenotypes, Contrib. Nephrol., 117, 154, 10.1159/000424812 Hudson, 1993, Type IV collagen: Structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndrome and diffuse leiomyomatosis, J. Biol. Chem., 268, 26033, 10.1016/S0021-9258(19)74270-7 Hostikka, 1990, Identification of a distinct type IV collagen α chain with restricted kidney distribution and assignment of its gene to the locus of X-linked Alport syndrome, Proc. Natl. Acad. Sci. USA, 87, 1606, 10.1073/pnas.87.4.1606 Mariyama, 1992, Colocalization of the genes for the α3(IV) and α(IV) chains of type IV collagen to chromosome 2 bands q35-q37, Genomics, 13, 809, 10.1016/0888-7543(92)90157-N Zhou, 1993, Deletion of the paired α5(IV) and α6(IV) collagen genes in inherited smooth muscle tumors, Science, 261, 1167, 10.1126/science.8356449 Hudson, 2003, Alport syndrome, Goodpasture syndrome and type IV collagen, N. Engl. J. Med., 348, 2543, 10.1056/NEJMra022296 Gubler, 1998, Alport's syndrome, thin basement membrane nephropathy, nail patella syndrome, and type III collagen glomerulopathy, 1207 Kashtan, 1986, Nephritogenic antigen determinants in epidermal and renal basement membranes of kindreds with Alport-type familial nephritis, J. Clin. Invest., 78, 1035, 10.1172/JCI112658 Kashtan, 1996, Immunohistochemical findings in Alport syndrome, 142 Ninomiya, 1995, Differential expression of two basement membrane collagen genes COL4A5 and COL4A6, demonstrated by immunofluorescence staining using peptide-specific monoclonal antibodies, J. Cell Biol., 130, 1219, 10.1083/jcb.130.5.1219 Alport, 1927, Hereditary familial congenital haemorrhagic nephritis, BMJ, 1, 504, 10.1136/bmj.1.3454.504 Atkin, 1988, Alport syndrome, 617 Gubler, 1992, Hétérogénéité génétique, clinique et morphologique dans le syndrome d'Alport, 15 Nielsen, 1977, Lenticonus anterior and Alport syndrome, Acta Ophthalmol. (Copenh.), 56, 518, 10.1111/j.1755-3768.1978.tb01365.x Polack, 1977, Macular lesions in Alport's disease, Am. J. Ophthalmol., 84, 533 Sohar, 1956, Renal disease, inner ear deafness, and ocular changes: new heredofamilial syndrome, Arch. Intern. Med., 97, 627, 10.1001/archinte.1956.00250230121013 Epstein, 1972, Hereditary macrothrombocytopathia, nephritis and deafness, Am. J. Med., 52, 299, 10.1016/0002-9343(72)90017-4 Churg, 1973, Pathologic characteristics of heteditary nephritis, Arch. Pathol., 95, 374 Hinglais, 1972, Characteristic ultrastructural lesion of the glomerular basement membrane in progressive hereditary nephritis (Alport's syndrome), Lab. Invest., 27, 473 Spear, 1972, Alport's syndrome: emphasizing electron microscopic studies of the glomerulus, Am. J. Pathol., 69, 213 Gubler, 1995, Autosomal recessive Alport syndrome: immunohistochemical study of type IV collagen chain distribution, Kidney Int., 47, 1142, 10.1038/ki.1995.163 Mazzucco, 1998, Ultrastructural and immunohistochemical findings in Alport's syndrome: a study of 108 patients from 97 Italian families with particular emphasis on COL4A5 gene mutation correlations, J. Am. Soc. Nephrol., 9, 1023, 10.1681/ASN.V961023 Feingold, 1985, Genetic heterogenerity of Alport syndrome, Kidney Int., 27, 672, 10.1038/ki.1985.63 Rhys, 1997, Recurrent corneal erosion associated with Alport's syndrome, Kidney Int., 52, 208, 10.1038/ki.1997.321 Jais, 2000, X-linked Alport syndrome. Natural history in 195 families and genotype-phenotype correlations in males, J. Am. Soc. Nephrol., 11, 649, 10.1681/ASN.V114649 Naito, 1996, Relationship between COL4A5 gene mutation and distribution of type IV collagen in male X-linked Alport syndrome, Kidney Int., 50, 304, 10.1038/ki.1996.316 Heidet, 2000, Glomerular expression of type IV collagen chains in normal and X-linked Alport syndrome kidneys, Am. J. Pathol., 156, 1901, 10.1016/S0002-9440(10)65063-8 Heidet, 2003, A human-mouse chimera of the alpha3alpha4alpha5(IV) collagen protomer rescues the renal phenotype in Col4a3-/- Alport mice, Am. J. Pathol., 163, 1633, 10.1016/S0002-9440(10)63520-1 Antignac, 1994, Deletions in the COL4A5 collagen gene in X-linked Alport syndrome. Characterization of the pathological transcripts in nonrenal cells and correlation with disease expression, J. Clin. Invest., 93, 1195, 10.1172/JCI117073 Barker, 1990, Identification of mutations in the COL4A5 collagen gene in Alport syndrome, Science, 247, 1224, 10.1126/science.2349482 Heikkilä, 1996, The type IV collagen family, 105 Hertz, 2001, Detection of mutations in the COL4A5 gene by SSCP in X-linked Alport syndrome, Hum. Mutat., 18, 141, 10.1002/humu.1163 Knebelmann, 1996, Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome, Am. J. Hum. Genet., 59, 1221 Lemmink, 1997, The clinical spectrum of type IV collagen mutation, Hum. Mutat., 9, 477, 10.1002/(SICI)1098-1004(1997)9:6<477::AID-HUMU1>3.0.CO;2-# Plant, 1999, Detection of mutations in COL4A5 in patients with Alport syndrome, Hum. Mutat., 13, 124, 10.1002/(SICI)1098-1004(1999)13:2<124::AID-HUMU4>3.0.CO;2-Z Renieri, 1996, X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene, Am. J. Hum. Genet., 58, 1192 Ellison, 2009, Novel human pathological mutations. Gene symbol: COL4A5. Disease: Alport syndrome, Hum. Genet., 126, 331 Savige, 2008, Gene symbol: COL4A5. Disease: Alport syndrome, Hum. Genet., 124, 301 Minucci, 2007, Novel human pathological mutations. Gene symbol: COL4A5. Disease: Alport syndrome, Hum. Genet., 122, 414 Tazon-Vega, 2007, Genetic testing for X-linked Alport syndrome by direct sequencing of COL4A5 cDNA from hair root RNA samples, Am J Kidney Dis, 50, 257.e1, 10.1053/j.ajkd.2007.05.004 Slajpah, 2007, Sixteen novel mutations identified in COL4A3, COL4A4, and COL4A5 genes in Slovenian families with Alport syndrome and benign familial hematuria, Kidney Int., 71, 1287, 10.1038/sj.ki.5002221 Wilson, 2007, A novel Cys1638Tyr NC1 domain substitution in alpha5(IV) collagen causes Alport syndrome with late onset renal failure without hearing loss or eye abnormalities, Nephrol. Dial. Transplant., 22, 1338, 10.1093/ndt/gfl793 Neri, 2005, Gene symbol: COL4A5. Disease: Alport syndrome, Hum. Genet., 118, 543 Hertz, 2005, Alport syndrome caused by inversion of a 21 Mb fragment of the long arm of the X-chromosome comprising exon 9 through 51 of the COL4A5 gene, Hum. Genet., 118, 23, 10.1007/s00439-005-0013-0 Nagel, 2005, Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome, Hum. Mutat., 26, 60, 10.1002/humu.9349 Wang, 2005, Detection of mutations in the COL4A5 gene by analyzing cDNA of skin fibroblasts, Kidney Int., 67, 1268, 10.1111/j.1523-1755.2005.00204.x Arrondel, 2004, A large tandem duplication within the COL4A5 gene is responsible for the high prevalence of Alport syndrome in French Polynesia, Kidney Int., 65, 2030, 10.1111/j.1523-1755.2004.00622.x Pan, 2004, Detection of COL4A5 gene mutations in Chinese patients with Alport's syndrome, Nephrol. Dial. Transplant., 19, 1123, 10.1093/ndt/gfh099 King, 2002, Unusual deep intronic mutations in the COL4A5 gene cause X linked Alport syndrome, Hum. Genet., 111, 548, 10.1007/s00439-002-0830-3 Heidet, 1997, Diffuse leiomyomatosis associated with X-linked Alport syndrome: Extracellular matrix study using immunohistochemistry and in situ hybridization, Lab. Invest., 76, 233 Heidet, 1995, Deletions of both α5(IV) and α6(IV) collagen genes in Alport syndrome and in Alport syndrome associated with smooth muscle tumours, Hum. Mol. Genet., 4, 99, 10.1093/hmg/4.1.99 Boye, 1998, Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome, Am. J. Hum. Genet., 63, 1329, 10.1086/302106 Heidet, 2001, Structure of the human type IV collagen gene COL4A3 and mutations in autosomal Alport syndrome, J. Am. Soc. Nephrol., 12, 97, 10.1681/ASN.V12197 Vende, 2009, Autosomal dominant Alport syndrome: clinical outcome, immunohistochemical and molecular analysis, J Am Soc Nephrol Van der Loop, 2000, Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation, Kidney Int., 58, 1870, 10.1111/j.1523-1755.2000.00358.x Arrondel, 2002, Expression of the non-muscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes, J. Am. Soc. Nephrol., 13, 65, 10.1681/ASN.V13165 Zheng, 1994, Canine X chromosome-linked hereditary nephritis: a genetic model for human X-linked hereditary nephritis resulting from a single base mutation in the gene encoding the α5chain of collagen type IV, Proc. Natl. Acad. Sci. USA, 91, 3989, 10.1073/pnas.91.9.3989 Hood, 2002, A novel model of autosomal dominant Alport syndrome in Dalmatian dogs, Nephrol. Dial. Transplant., 17, 2094, 10.1093/ndt/17.12.2094 Lees, 1998, A model of autosomal recessive Alport syndrome in English cocker spaniel dogs, Kidney Int., 54, 706, 10.1046/j.1523-1755.1998.00062.x Cosgrove, 1996, Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome, Genes Dev., 10, 2981, 10.1101/gad.10.23.2981 Miner, 1996, Molecular and functional defects in kidneys of mice lacking collagen α3(IV): implications for Alport syndrome, J. Cell Biol., 135, 1403, 10.1083/jcb.135.5.1403 Rheault, 2004, Mouse model of X-linked Alport syndrome, J. Am. Soc. Nephrol., 15, 1466, 10.1097/01.ASN.0000130562.90255.8F Rogers, 1973, Familial benign essential hematuria, Arch. Intern. Med., 131, 257, 10.1001/archinte.1973.00320080093013 Schröder, 1990, Renal biopsy and family studies in 65 children with isolated hematuria, Acta Paediatr. Scand., 79, 630, 10.1111/j.1651-2227.1990.tb11527.x Callís, 1999, Long-term effects of cyclosporine A in Alport's syndrome, Kidney Int., 55, 1051, 10.1046/j.1523-1755.1999.0550031051.x Chen, 2003, Cyclosporine a slows the progressive renal disease of Alport syndrome (X-linked hereditary nephritis): results from a canine model, J. Am. Soc. Nephrol., 14, 690, 10.1097/01.ASN.0000046964.15831.16 Charbit, 2007, Cyclosporin therapy in patients with Alport syndrome, Pediatr. Nephrol., 22, 57, 10.1007/s00467-006-0227-y Zeisberg, 2006, Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease, PLoS Med., 3, e100, 10.1371/journal.pmed.0030100 LeBleu, 2009, Stem cell therapies benefit Alport syndrome, J. Am. Soc. Nephrol., 20, 2359, 10.1681/ASN.2009010123 Ninichuk, 2005, Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease, J. Am. Soc. Nephrol., 16, 977, 10.1681/ASN.2004100871